
William G. Wright
Examiner (ID: 13821)
| Most Active Art Unit | 1106 |
| Art Unit(s) | 1106, 1754 |
| Total Applications | 637 |
| Issued Applications | 554 |
| Pending Applications | 0 |
| Abandoned Applications | 83 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9295397
[patent_doc_number] => 20140039031
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-06
[patent_title] => 'PHARMACEUTICAL FORMULATIONS OF ACETYL-11-KETO-B-BOSWELLIC ACID, DIINDOLYLMETHANE, AND CURCUMIN FOR PHARMACEUTICAL APPLICATIONS'
[patent_app_type] => utility
[patent_app_number] => 14/001098
[patent_app_country] => US
[patent_app_date] => 2012-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 14101
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14001098
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/001098 | PHARMACEUTICAL FORMULATIONS OF ACETYL-11-KETO-B-BOSWELLIC ACID, DIINDOLYLMETHANE, AND CURCUMIN FOR PHARMACEUTICAL APPLICATIONS | Feb 22, 2012 | Abandoned |
Array
(
[id] => 8671419
[patent_doc_number] => 20130045957
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-21
[patent_title] => 'Prevention of and Recovery from Drug-Induced Ototoxicity'
[patent_app_type] => utility
[patent_app_number] => 13/398665
[patent_app_country] => US
[patent_app_date] => 2012-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 21147
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13398665
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/398665 | Prevention of and Recovery from Drug-Induced Ototoxicity | Feb 15, 2012 | Abandoned |
Array
(
[id] => 9295427
[patent_doc_number] => 20140039061
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-06
[patent_title] => 'HYALURONIC ACID COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 13/983448
[patent_app_country] => US
[patent_app_date] => 2012-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 13552
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13983448
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/983448 | Hyaluronic acid composition | Feb 2, 2012 | Issued |
Array
(
[id] => 9149087
[patent_doc_number] => 20130303610
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-14
[patent_title] => 'PESTICIDAL COMPOSITION AND METHOD FOR CONTROLLING PESTS'
[patent_app_type] => utility
[patent_app_number] => 13/980249
[patent_app_country] => US
[patent_app_date] => 2012-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6187
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13980249
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/980249 | PESTICIDAL COMPOSITION AND METHOD FOR CONTROLLING PESTS | Jan 19, 2012 | Abandoned |
Array
(
[id] => 8503227
[patent_doc_number] => 20120302636
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-29
[patent_title] => 'METHOD OF TREATING A DISORDER ASSOCIATED WITH MTP'
[patent_app_type] => utility
[patent_app_number] => 13/328787
[patent_app_country] => US
[patent_app_date] => 2011-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18984
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13328787
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/328787 | METHOD OF TREATING A DISORDER ASSOCIATED WITH MTP | Dec 15, 2011 | Abandoned |
Array
(
[id] => 9223629
[patent_doc_number] => 20140018404
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-16
[patent_title] => 'CONTROLLED RELEASE ORAL DOSAGE FORMS OF POORLY SOLUBLE DRUGS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/993046
[patent_app_country] => US
[patent_app_date] => 2011-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 17559
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13993046
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/993046 | CONTROLLED RELEASE ORAL DOSAGE FORMS OF POORLY SOLUBLE DRUGS AND USES THEREOF | Dec 14, 2011 | Abandoned |
Array
(
[id] => 8896795
[patent_doc_number] => 08476316
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-07-02
[patent_title] => '3-methanesulfonylpropionitrile for treating inflammation and pain'
[patent_app_type] => utility
[patent_app_number] => 13/324777
[patent_app_country] => US
[patent_app_date] => 2011-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9532
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13324777
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/324777 | 3-methanesulfonylpropionitrile for treating inflammation and pain | Dec 12, 2011 | Issued |
Array
(
[id] => 8290437
[patent_doc_number] => 20120178757
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-12
[patent_title] => 'Method For The Prevention Of Cancer Metastasis'
[patent_app_type] => utility
[patent_app_number] => 13/314437
[patent_app_country] => US
[patent_app_date] => 2011-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 12066
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13314437
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/314437 | Method For The Prevention Of Cancer Metastasis | Dec 7, 2011 | Abandoned |
Array
(
[id] => 9015617
[patent_doc_number] => 20130230581
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-05
[patent_title] => 'EGFR ANTAGONIST FOR THE TREATMENT OF HEART DISEASE'
[patent_app_type] => utility
[patent_app_number] => 13/825605
[patent_app_country] => US
[patent_app_date] => 2011-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 12400
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13825605
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/825605 | EGFR ANTAGONIST FOR THE TREATMENT OF HEART DISEASE | Nov 29, 2011 | Abandoned |
Array
(
[id] => 8241041
[patent_doc_number] => 20120149775
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-14
[patent_title] => 'METHODS FOR PREVENTING AND IMPROVING SKIN ELASTIC PROPERTY LOSS'
[patent_app_type] => utility
[patent_app_number] => 13/306478
[patent_app_country] => US
[patent_app_date] => 2011-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5971
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13306478
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/306478 | METHODS FOR PREVENTING AND IMPROVING SKIN ELASTIC PROPERTY LOSS | Nov 28, 2011 | Abandoned |
Array
(
[id] => 8228474
[patent_doc_number] => 20120142684
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-07
[patent_title] => 'COMPOUNDS AND METHODS FOR SKIN REPAIR'
[patent_app_type] => utility
[patent_app_number] => 13/306637
[patent_app_country] => US
[patent_app_date] => 2011-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6864
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13306637
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/306637 | COMPOUNDS AND METHODS FOR SKIN REPAIR | Nov 28, 2011 | Abandoned |
Array
(
[id] => 9135573
[patent_doc_number] => 20130296288
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-07
[patent_title] => 'ORGANIC ELECTROLUMINESCENT DEVICE'
[patent_app_type] => utility
[patent_app_number] => 13/994766
[patent_app_country] => US
[patent_app_date] => 2011-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16660
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13994766
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/994766 | ORGANIC ELECTROLUMINESCENT DEVICE | Nov 23, 2011 | Abandoned |
Array
(
[id] => 8186610
[patent_doc_number] => 20120115835
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-10
[patent_title] => 'METHODS FOR TREATMENT OF BACTERIAL INFECTIONS'
[patent_app_type] => utility
[patent_app_number] => 13/283406
[patent_app_country] => US
[patent_app_date] => 2011-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 5822
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0115/20120115835.pdf
[firstpage_image] =>[orig_patent_app_number] => 13283406
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/283406 | METHODS FOR TREATMENT OF BACTERIAL INFECTIONS | Oct 26, 2011 | Abandoned |
Array
(
[id] => 10174961
[patent_doc_number] => 09205149
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-12-08
[patent_title] => 'Pharmaceutical topical composition of mupirocin'
[patent_app_type] => utility
[patent_app_number] => 13/879008
[patent_app_country] => US
[patent_app_date] => 2011-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4703
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13879008
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/879008 | Pharmaceutical topical composition of mupirocin | Oct 18, 2011 | Issued |
Array
(
[id] => 8186604
[patent_doc_number] => 20120115833
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-10
[patent_title] => 'METHOD OF TREATING HEPATOCELLULAR CARCINOMA'
[patent_app_type] => utility
[patent_app_number] => 13/274363
[patent_app_country] => US
[patent_app_date] => 2011-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4779
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0115/20120115833.pdf
[firstpage_image] =>[orig_patent_app_number] => 13274363
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/274363 | METHOD OF TREATING HEPATOCELLULAR CARCINOMA | Oct 16, 2011 | Abandoned |
Array
(
[id] => 8095741
[patent_doc_number] => 20120083471
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-04-05
[patent_title] => 'Novel Compounds, Pharmaceutical Compositions Containing Same, Methods of Use for Same, and Methods for Preparing Same'
[patent_app_type] => utility
[patent_app_number] => 13/273740
[patent_app_country] => US
[patent_app_date] => 2011-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 22951
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0083/20120083471.pdf
[firstpage_image] =>[orig_patent_app_number] => 13273740
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/273740 | Novel Compounds, Pharmaceutical Compositions Containing Same, Methods of Use for Same, and Methods for Preparing Same | Oct 13, 2011 | Abandoned |
Array
(
[id] => 8228525
[patent_doc_number] => 20120142738
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-07
[patent_title] => 'Pharmaceutical composition for treating dermatological autoimmune diseases'
[patent_app_type] => utility
[patent_app_number] => 13/272750
[patent_app_country] => US
[patent_app_date] => 2011-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3093
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13272750
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/272750 | Pharmaceutical composition for treating dermatological autoimmune diseases | Oct 12, 2011 | Abandoned |
Array
(
[id] => 8228572
[patent_doc_number] => 20120142776
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-07
[patent_title] => 'METHODS AND COMPOSITIONS FOR INDUCING PHYSIOLOGICAL HYPERTROPHY'
[patent_app_type] => utility
[patent_app_number] => 13/272910
[patent_app_country] => US
[patent_app_date] => 2011-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 35
[patent_no_of_words] => 37302
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13272910
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/272910 | METHODS AND COMPOSITIONS FOR INDUCING PHYSIOLOGICAL HYPERTROPHY | Oct 12, 2011 | Abandoned |
Array
(
[id] => 9162153
[patent_doc_number] => 20130310431
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-21
[patent_title] => 'USES FOR SUBSTITUTED 2-AMINO-THIAZOLONES IN TREATING ALZHEIMER\'S DISEASE'
[patent_app_type] => utility
[patent_app_number] => 13/879229
[patent_app_country] => US
[patent_app_date] => 2011-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4208
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13879229
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/879229 | USES FOR SUBSTITUTED 2-AMINO-THIAZOLONES IN TREATING ALZHEIMER'S DISEASE | Oct 10, 2011 | Abandoned |
Array
(
[id] => 8301971
[patent_doc_number] => 20120184522
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-19
[patent_title] => 'THERAPEUTIC APPLICATIONS IN THE CARDIOVASCULAR FIELD OF QUINAZOLINEDIONE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 13/268371
[patent_app_country] => US
[patent_app_date] => 2011-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35167
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13268371
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/268371 | Therapeutic applications in the cardiovascular field of quinazolinedione derivatives | Oct 6, 2011 | Issued |